Title of article
A Review on Hematologic Malignant Patients Infected with 2019 Novel Coronavirus
Author/Authors
Lotfali, Ensieh Department of Medical Parasitology and Mycology - School of Medicine - Shahid Beheshti University of Medical Sciences, Tehran , Ghasemi, Reza , School of Medicine - Shahid Beheshti University of Medical Sciences, Tehran , Mardani, Masoud Shahid Beheshti University of Medial Sciences, Tehran , Fattahi, Azam Tehran University of Medical Sciences, Tehran , Rezaei, Kamran School of Medicine - Shahid Beheshti University of Medical Sciences, Tehran , Toreyhi, Hossein School of Medicine - Shahid Beheshti University of Medical Sciences, Tehran , Abolghasemi, Sara Shahid Beheshti University of Medial Sciences, Tehran
Pages
8
From page
1
To page
8
Abstract
Since late 2019, when novel coronavirus pneumonia emerged in China and spread worldwide, there has been a need for data concerning the clinical characteristics of infected immunocompromised patients. It has been reported that a significant mortality rate occurs in individuals with underlying comorbidities such as hematologic malignancies. Therefore, it is vital to illustrate the clinical manifestations and outcomes of COVID-19 in these vulnerable patients and identify safe therapeutic strategies. This study reviewed the clinical course, laboratory findings, and risk factors associated with hematologic malignant patients with COVID-19 along with the management and therapeutic regimens.
Keywords
Coronavirus , COVID-19 , SARS-CoV-2 , Severe Acute Respiratory Syndrome Coronavirus 2 , Hematological Malignant Patients
Journal title
Archives of Clinical Infectious Diseases
Serial Year
2020
Record number
2544439
Link To Document